Table 2 Renal function at the start of therapy
From: Evaluation of intravenous voriconazole in patients with compromised renal function
Parameter | Voriconazole | Caspofungin | Fluconazole | p-value for overall difference |
|---|---|---|---|---|
Baseline Scr (mg/dL) | 2.1 (0.9) | 2.8 (1.5) | 2.2 (1.3) | 0.04 |
Baseline BUN (mg/dL) | 33.3 (31.9) | 56.5 (39.8) | 48.7 (28.7) | 0.04 |
Baseline Clcr (mL/min) | ||||
Cockcroft-Gault method | 33.9 (9.0) | 28.2 (12.0) | 30.4 (10.3) | 0.14 |
MDRD1 calculation | 33.3 (14.0) | 28.4 (17.1) | 32.1 (15.5) | 0.36 |